GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Synovis Life Technologies, Inc. (SYNO) [hlAlert]

Rating:
Buy SYNO
up 23.44 %

Synovis Life Technologies, Inc. (SYNO) rated Buy

Posted on: Friday,  Oct 12, 2007  9:25 AM ET by Northland Securities

Northland Securities rated Buy Synovis Life Technologies, Inc. (NASDAQ: SYNO) on 10/12/2007, when the stock price was $22.69.
Since then, Synovis Life Technologies, Inc. has gained 23.45% as of 02/14/2012's recent price of $28.01.
If you would have followed this Northland Securities's recommendation on SYNO, you would have gained 23.44% of your investment in 1586 days.

Synovis Life Technologies, Inc. is a diversified medical device company engaged in developing, manufacturing, marketing and selling implantable biomaterial products, devices for microsurgery and surgical tools. Its products serve an array of medical markets, including general surgery, bariatric, vascular, cardiac, thoracic, neurological and microsurgery. The Company is engaged in the development and manufacturing of implantable biomaterial products for use by surgeons in various procedures where reinforcing, reconstructing and repairing tissue and preventing leaks of air, blood or other body fluids. In January 2008, the Company announced that it had closed on the previously announced sale of substantially all of the assets of its interventional business to Heraeus Vadnais and related entities.

Our equity research effort attempts to identify high potential small-cap investment ideas. We offer traditional sell-side research services with a particular focus on unearthing information that either supports or challenges our investment thesis. We strive to continuously provide our institutional client base with timely and insightful thinking.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/12/2007 9:25 AM Buy
None
22.69 28.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  22.47 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy